BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26861062)

  • 1. Oncological outcomes and prognostic factors after nephron-sparing surgery in renal cell carcinoma.
    López-Costea MÁ; Bonet X; Pérez-Reggeti J; Etcheverry B; Vigués F
    Int Urol Nephrol; 2016 May; 48(5):681-6. PubMed ID: 26861062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes.
    Bigot P; Hétet JF; Bernhard JC; Fardoun T; Audenet F; Xylinas E; Ploussard G; Pignot G; Bessede T; Ouzaid I; Robine E; Brureau L; Merigot de Treigny O; Maurin C; Long JA; Rouffilange J; Hoarau N; Lebdai S; Rouprêt M; Bastien L; Neuzillet Y; Mongiat-Artus P; Verhoest G; Zerbib M; Ravery V; Rigaud J; Bellec L; Baumert H; Chautard D; Bensalah K; Escudier B; Paparel P; Grenier N; Rioux-Leclercq N; Azzouzi AR; Soulié M; Patard JJ
    Clin Genitourin Cancer; 2014 Feb; 12(1):e19-27. PubMed ID: 24210610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephron-sparing surgery across a nation - outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit.
    Fernando A; Fowler S; O'Brien T;
    BJU Int; 2016 Jun; 117(6):874-82. PubMed ID: 26469291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcomes of nephron sparing nephrectomy. 17-year analysis.
    Aguilera Bazan A; Bañuelos B; Alonso-Dorrego JM; Diez J; Cisneros J; De la Peña Barthel J
    Arch Esp Urol; 2014 Apr; 67(3):237-42. PubMed ID: 24840588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
    Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
    Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictors of positive surgical margins after nephron-sparing surgery for renal cell carcinoma: retrospective analysis on 298 consecutive patients].
    Schiavina R; Borghesi M; Chessa F; Rizzi S; Martorana G
    Urologia; 2014; 81(1):40-5. PubMed ID: 24744214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
    Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
    World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
    Kim EH; Jain S; Benway BM; Figenshau RS
    BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors.
    Marchiñena PG; Tirapegui S; Gonzalez IT; Jurado A; Gueglio G
    Int Braz J Urol; 2018; 44(3):475-482. PubMed ID: 29368873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance.
    Lopez-Costea MA; Fumadó L; Lorente D; Riera L; Miranda EF
    BJU Int; 2010 Sep; 106(5):645-8. PubMed ID: 20067450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imperative and elective indications for nephron-sparing surgery for renal tumors: long-term oncological follow-up.
    Roos FC; Pahernik S; Brenner W; Thüroff JW
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S70-6. PubMed ID: 20094960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
    Pertia A; Managadze L; Chkhotua A
    Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of surgical margin on cancer-specific survival in patients treated with nephron-sparing surgery.
    Kizilay F; Eskidemir U; Bahceci T; Simsir A; Ozdemir H; Sarsik B; Turna B
    Niger J Clin Pract; 2019 Oct; 22(10):1396-1402. PubMed ID: 31607729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication.
    Patard JJ; Pantuck AJ; Crepel M; Lam JS; Bellec L; Albouy B; Lopes D; Bernhard JC; Guillé F; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferriere JM; Abbou CC; Colombel M; Belldegrun AS
    Eur Urol; 2007 Jul; 52(1):148-54. PubMed ID: 17240036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
    Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
    Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
    Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
    J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.